Phage Display Solutions

Unmatched quality and innovation to unlock your peptide and antibody discoveries

LEARN MORE LETS TALK

Leading Phage Display

At Cell Origins, our mission is to revolutionize peptide and antibody discovery by providing phage display products and services of unmatched quality. We understand the importance of using high-quality libraries for biopanning experiments and the need for innovation in designing successful phage display affinity selections.


Whether you are exploring new avenues of discovery or expanding existing ones, we have the experience and resources to help you achieve your scientific goals. Having decades of experience and expertise in phage display technology, we strive to provide the best solutions for other scientists. With our products and services, you can spend less time and cost on phage display and instead focus on leveraging your peptides and antibodies.

LIBRARIES

Premade and customized 

peptide and antibody phage 

display libraries

SCREENING

Phage display affinity 

selections and peptide 

and antibody screening

PRODUCTS

Phage display vectors 

and E. coli strains


CONSULTING

Phage display biopanning, 

screening, affinity maturation,

and more

What Other Scientists Say About Us

Blog Posts

Knowing When to Transition Your Pharmaceutical Discovery to Pre-IND Work: 6 Key Indicators

By LeAnn Qi • March 19, 2024
Transitioning a pharmaceutical project from the discovery stage to pre-investigative new drug application (pre-IND) work is a momentous step, marking the shift from conceptual research to the prospect of new therapeutics. For pharmaceutical scientists, this is the stage that necessitates a meticulous evaluation process because each progression is laden with significant resource allocation and regulatory implications. Here are six critical checkpoints to confirm before taking the leap from drug discovery to the pre-IND phase.

Transitioning from Drug Discovery to Pre-IND Work

By LeAnn Qi • March 5, 2024
The path of a compound from its identification in drug discovery to the commencement of formal human trials is marked by a crucial transitional phase - the pre-Investigational New Drug (pre-IND) work. This phase lays the groundwork for regulatory scrutiny and sets the trajectory for clinical success. For pharmaceutical researchers dedicated to the relentless pursuit of novel therapies, understanding the nuances of this transition is key to navigating the complex landscape of drug development.
Dr. Susan Deutscher

Women in Phage Display: Dr. Susan Deutscher

By Mette Soendergaard • March 10, 2023
As we celebrate Women's History Month at Cell Origins, we find it important to recognize the many women scientists who have contributed to the advancement of phage display technology. Phage display is an extremely powerful method for discovering peptides and antibodies for drug discovery, studying protein interactions, and elucidating structure-function relationships in a wide variety of biological contexts.
More